Journal
RADIOTHERAPY AND ONCOLOGY
Volume 109, Issue 1, Pages 95-99Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2013.10.011
Keywords
Radiation pneumonitis; Stereotactic radiotherapy; Lung tumors
Funding
- Varian Medical Systems
Ask authors/readers for more resources
Purpose: To identify dosimetric factors that predict development of radiation pneumonitis (RP) following stereotactic or hypofractionated radiotherapy for lung tumors. Methods: Seventy-nine consecutive patients with either a planning target volume (PTV) > 100 cm(3) (n = 69) or prior pneumonectomy or bi-lobectomy (n = 13) were identified. Radiation doses (range: 5-50 Gy, with 5 Gy increments) were converted to equivalent doses (EQD(2) (Gy)) (alpha/beta = 3). Total lung (TL), ipsilateral (IL) and contralateral lung (CL) volumes minus PTV, receiving 5 Gy (V5) up to 50 Gy (V50) and mean lung dose (MLD) were analyzed. Predictors of grade >= 3 RP (CTCAEv4.03) were identified with concordance-statistics (C-statistic) and p-values used to quantify the performance of the model. Factors found to be significant were entered into a recursive partitioning analysis (RPA). Results: Median PTV was 150 cm(3). Grade >= 3 RP was observed in 8 patients (10%). In univariable analysis, CL-MLD, CL-V5-15, TL-MLD, TL-V5-V10 and ITV size were predictive of RP (p < 0.05). In multivariable analysis, contralateral MLD (p = .007) and IW (p = .063) were the strongest predictors of grade >= 3 RP, with excellent discrimination (C-statistic: 0.868). Conclusion: Contralateral MLD and ITV size are both strong predictors of grade >= 3 RP post treatment. Planning constraints should aim to keep contralateral MLD below 3.6 Gy. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available